Literature DB >> 11444848

Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers.

Y Omoto1, Y Kobayashi, K Nishida, E Tsuchiya, H Eguchi, K Nakagawa, Y Ishikawa, T Yamori, H Iwase, Y Fujii, M Warner, J A Gustafsson, S I Hayashi.   

Abstract

The higher frequency of human lung adenocarcinoma in females than in males, strongly suggests the involvement of gender dependent factors in the etiology of this disease. This is the first investigation of estrogen receptor (ER) beta in human lung. Immunohistochemical staining revealed ERbeta expression in normal lung and in atypical adenomatous hyperplasia (AAH), considered as a precancerous lesion for adenocarcinomas. Adenocarcinomas showed significantly higher expression of ERbeta than squamous cell carcinomas. On the contrary, ERalpha expression was not detected in all cases. The functional integrity of ERbeta such as the binding ability to estrogen responsive element (ERE) and transcriptional activity was confirmed using a human lung cancer cell line, RERF-LC-OK. Colony formation of this cell was significantly reduced in the presence of pure antiestrogen. We conclude that ERbeta, but not ERalpha, is present in lung tissues with an important physiological function in normal lung. Furthermore, ERbeta may play a role in growth and development of adenocarcinomas. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444848     DOI: 10.1006/bbrc.2001.5158

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  61 in total

1.  Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancer.

Authors:  Sri Navaratnam; Georgios Skliris; Gefei Qing; Shantanu Banerji; Ketan Badiani; Dongsheng Tu; Penelope A Bradbury; Natasha B Leighl; Frances A Shepherd; Janet Nowatzki; Alain Demers; Leigh Murphy
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

2.  Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis.

Authors:  Michael J Jarzynka; Ping Guo; Ifat Bar-Joseph; Bo Hu; Shi-Yuan Cheng
Journal:  Int J Oncol       Date:  2006-02       Impact factor: 5.650

3.  The genome landscape of ERalpha- and ERbeta-binding DNA regions.

Authors:  Yawen Liu; Hui Gao; Troels Torben Marstrand; Anders Ström; Eivind Valen; Albin Sandelin; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-13       Impact factor: 11.205

4.  Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.

Authors:  Pamela A Hershberger; Laura P Stabile; Beatriz Kanterewicz; Mary E Rothstein; Chris T Gubish; Stephanie Land; Yongli Shuai; Jill M Siegfried; Mark Nichols
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-19       Impact factor: 4.292

5.  Microarray analysis of altered gene expression in ERbeta-overexpressing HEK293 cells.

Authors:  Chunyan Zhao; Milica Putnik; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  Endocrine       Date:  2009-08-13       Impact factor: 3.633

6.  The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.

Authors:  Nadiyah Kazmi; Diana C Márquez-Garbán; Lilia Aivazyan; Nalo Hamilton; Edward B Garon; Lee Goodglick; Richard J Pietras
Journal:  Lung Cancer Manag       Date:  2012-12

Review 7.  Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer.

Authors:  Hideki Kawai
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  Nicotine promotes tumor growth and metastasis in mouse models of lung cancer.

Authors:  Rebecca Davis; Wasia Rizwani; Sarmistha Banerjee; Michelle Kovacs; Eric Haura; Domenico Coppola; Srikumar Chellappan
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

9.  Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas.

Authors:  Shirley K Knauer
Journal:  J Oncol       Date:  2009-09-24       Impact factor: 4.375

10.  Antiproliferative effect of exemestane in lung cancer cells.

Authors:  Angelos Koutras; Efstathia Giannopoulou; Ismini Kritikou; Anna Antonacopoulou; T R Jeffry Evans; Athanasios G Papavassiliou; Haralabos Kalofonos
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.